Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Merck & Co
(NY:
MRK
)
118.45
+0.99 (+0.84%)
Official Closing Price
Updated: 7:00 PM EDT, Aug 30, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
8,876,480
Open
117.27
Bid (Size)
118.29 (2)
Ask (Size)
118.87 (1)
Prev. Close
117.46
Today's Range
117.15 - 118.75
52wk Range
99.14 - 134.63
Shares Outstanding
2,531,374,696
Dividend Yield
2.47%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
2 Dividend Stocks You Can Safely Hold Through a Recession
Today 8:45 EDT
These stocks can help you sleep peacefully at night, even in bad times.
Via
The Motley Fool
Behind the Scenes of Merck & Co's Latest Options Trends
August 30, 2024
Via
Benzinga
Performance
YTD
+4.60%
+4.60%
1 Month
+5.47%
+5.47%
3 Month
-7.76%
-7.76%
6 Month
-4.51%
-4.51%
1 Year
+10.18%
+10.18%
More News
Read More
Uncovering Dividend Opportunities with NYSE:MRK.
August 30, 2024
Via
Chartmill
Moderna And BioNTech Bet On Personalized Cancer Vaccines To Revive Fortunes After Dwindling COVID-19 Vaccine Sales
August 29, 2024
Via
Benzinga
Exposures
COVID-19
Merck Pulls Plug On Two Keytruda Late-Stage Studies On Underwhelming Data
August 29, 2024
Via
Benzinga
Merck to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
August 29, 2024
From
Merck & Co., Inc.
Via
Business Wire
Comparing Merck & Co With Industry Competitors In Pharmaceuticals Industry
August 28, 2024
Via
Benzinga
NYSE:MRK is probably undervalued for the fundamentals it is displaying.
August 28, 2024
Via
Chartmill
Merck Provides Update on Phase 3 KEYNOTE-867 and KEYNOTE-630 Trials
August 29, 2024
From
Merck & Co., Inc.
Via
Business Wire
Dow Jones Industrial Average Pares Recent Gains As Investors Take A Pause
August 28, 2024
Via
Talk Markets
Topics
Stocks
Exposures
US Equities
12 Dividend Stocks to Earn Income Every Month
August 28, 2024
Via
The Motley Fool
Options: An Unlikely Source Of Income
August 27, 2024
Via
Talk Markets
Merck & Co's Options: A Look at What the Big Money is Thinking
August 26, 2024
Via
Benzinga
Merck & Co's Options: A Look at What the Big Money is Thinking
August 19, 2024
Via
Benzinga
3 Ways the Democratic Party's Platform Could Impact Biotech and Pharma Stocks if Implemented
August 27, 2024
Via
The Motley Fool
Merck Announces Phase 3 Trial Initiation for Bomedemstat, an Investigational Candidate for the Treatment of Certain Patients With Essential Thrombocythemia
August 27, 2024
From
Merck & Co., Inc.
Via
Business Wire
Merck Receives European Commission Approval for WINREVAIR™ (sotatercept) in Combination With Other Pulmonary Arterial Hypertension (PAH) Therapies, for the Treatment of PAH in Adult Patients With Functional Class II-III
August 26, 2024
From
Merck & Co., Inc.
Via
Business Wire
Week In Review: Multitude Out-Licenses Tissue Factor ADC To Adcendo In $1 Billion Deal
August 24, 2024
Via
Talk Markets
MarketBeat Week in Review – 8/19 - 8/23
August 24, 2024
Via
MarketBeat
Topics
Economy
Exposures
Economy
Interest Rates
Cancer Medicines From Merck, Bristol Myers And BeiGene In Question, As FDA Committee To Discuss Limiting PD-1 Drugs For Stomach Cancer
August 23, 2024
Via
Benzinga
Exposures
Product Safety
Merck's Ebola Vaccine Showed 84% Effectiveness During Large Outbreak In Africa
August 22, 2024
Via
Benzinga
Big Pharma Stocks: Who’s Leading The Race And Who’s Slipping?
August 20, 2024
Via
Talk Markets
Biotech Bull Market: 3 Ways To Play It
August 20, 2024
Via
Talk Markets
Topics
Economy
Exposures
Interest Rates
Merck's Stock Dip Offers a Buying Opportunity: Here’s Why
August 20, 2024
Via
MarketBeat
Topics
Intellectual Property
Exposures
Intellectual Property
Moderna Dips on Q2 Earnings But Can It Rip on a Short Squeeze?
August 19, 2024
Via
MarketBeat
Exposures
COVID-19
Product Safety
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.